Quick Reference | Differentiation Syndrome (DS): AML Therapy

Other Resources

Quick Reference | Differentiation Syndrome (DS): AML Therapy

Key Takeaways | Challenging Cases in Cancer: Low-Risk MDS Program

Key Takeaways | Challenging Cases in Cancer: AML

Common Agents

      1. IDH inhibitors: Ivosidenib, Enasidenib (14-19%)

      1. Menin inhibitors: Revumenib, Ziftomenib (25%)

      1. FLT3 inhibitors: Gilteritinib, Quizartinib (less common: 3-5%)

    Diagnosis: 2 or more symptoms required
    ➢ 7 KEY DIAGNOSTIC CRITERIA & FREQUENCY OF SYMPTOMS

    1. Dyspnea/Hypoxia Shortness of breath, low O2 saturation (25.8%)
    2. Pulmonary Infiltrates/Effusions Imaging or clinical findings (22.6%)
    3. Edema/Weight Gain Peripheral edema, rapid weight gain (22.6%)
    4. Fever Unexplained temperature elevation (19.4%)
    5. Acute Renal Failure Rising creatinine (6.5%)
    6. Unexplained Leukocytosis WBC >10,000 cell/L (common)
    7. Rash/Lymphadenopathy More common with IDH inhibitors (3.2%)

    Severity Grading
    Severe 2 signs/symptoms present
    Moderate 3-4 signs/symptoms present
    Severe 5 signs/symptoms present

    Next steps upon confirmation of suspected DS

        1. Notify oncology team immediately-patients needevaluation TODAY!

        1. Consider preparing for admission-Many patients require hospitalization.

        1. Anticipate dexamethasone order: IV or PO for a minimum of 3 days.

        1. Do not stop targeted therapy without oncology consultation. Recommendationsfor holding vary on
          agent

      Next steps upon confirmation of suspected DS

          • When in doubt, escalate to the oncology team!

          • Dyspnea is a common presenting symptom in AML, often attributable to anemia. A thorough medication review is essential to distinguish anemia-related symptoms from those associated with differentiation syndrome.

          • A single sign or symptom is insufficient for diagnosis; assessment should focus on patterns of presentation.

          • Prompt dexamethasone initiation is key to successful DS management.

        Let’s Get In Touch

        We collaborate with clients to develop customized, education-focused experiences that align with organizational objectives, comply with regulatory standards, and support meaningful professional growth.

        Update Your Cookie Consent

        Your Privacy Choices

        Fast4ward Learning uses cookies and similar technologies to improve site functionality, understand how visitors use our website, and support a secure browsing experience. You can accept or decline non-essential cookies at any time. Essential cookies remain active to ensure the site works properly. Learn more about how we use cookies.

        Newsletter Signup

        Cookie Consent

        Your Privacy Choices

        Fast4ward Learning uses cookies and similar technologies to improve site functionality, understand how visitors use our website, and support a secure browsing experience. You can accept or decline non-essential cookies at any time. Essential cookies remain active to ensure the site works properly. Learn more about how we use cookies.